• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Sight Sciences Inc. (Amendment)

    2/14/23 11:01:54 AM ET
    $SGHT
    Medical/Dental Instruments
    Health Care
    Get the next $SGHT alert in real time by email
    SC 13G/A 1 d417146dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Sight Sciences, Inc.

    (Name of Issuer)

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)

     

    82657M105

    (CUSIP Number)

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications:

    Evan K. Hall, Esq.

    Haynes and Boone, LLP

    2323 Victory Avenue, Suite 700

    Dallas, Texas 75219

    (214) 651-5000

     

     

     


    CUSIP No. 82657M105

     

      1.    

      Names of Reporting Persons.

     

      HEP Partners LLC

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

     

      (a)  ☐        (b)  ☑

      3.  

      SEC Use Only

     

      4.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5.    

      Sole Voting Power

     

      0

       6.  

      Shared Voting Power

     

      0

       7.  

      Sole Dispositive Power

     

      0

       8.  

      Shared Dispositive Power

     

      0

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10.  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

      ☐

    11.  

      Percent of Class Represented by Amount in Row (9)

     

      0.0%

    12.  

      Type of Reporting Person (See Instructions)

     

      OO, IA


    CUSIP No. 82657M105

     

      1.    

      Names of Reporting Persons.

     

      HH Sight LLC

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

     

      (a)  ☐        (b)  ☑

      3.  

      SEC Use Only

     

      4.  

      Citizenship or Place of Organization

     

      Texas

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5.    

      Sole Voting Power

     

      0

       6.  

      Shared Voting Power

     

      0

       7.  

      Sole Dispositive Power

     

      0

       8.  

      Shared Dispositive Power

     

      0

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10.  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

      ☐

    11.  

      Percent of Class Represented by Amount in Row (9)

     

      0.0%

    12.  

      Type of Reporting Person (See Instructions)

     

      OO


    CUSIP No. 82657M105

     

      1.    

      Names of Reporting Persons.

     

      HH Sight Partners GP, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

     

      (a)  ☐        (b)  ☑

      3.  

      SEC Use Only

     

      4.  

      Citizenship or Place of Organization

     

      Texas

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5.    

      Sole Voting Power

     

      0

       6.  

      Shared Voting Power

     

      0

       7.  

      Sole Dispositive Power

     

      0

       8.  

      Shared Dispositive Power

     

      0

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10.  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

      ☐

    11.  

      Percent of Class Represented by Amount in Row (9)

     

      0.0%

    12.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 82657M105

     

      1.    

      Names of Reporting Persons.

     

      HH Sight Partners, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

     

      (a)  ☐        (b)  ☑

      3.  

      SEC Use Only

     

      4.  

      Citizenship or Place of Organization

     

      Texas

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5.    

      Sole Voting Power

     

      0

       6.  

      Shared Voting Power

     

      0

       7.  

      Sole Dispositive Power

     

      0

       8.  

      Shared Dispositive Power

     

      0

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10.  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

      ☐

    11.  

      Percent of Class Represented by Amount in Row (9)

     

      0.0%

    12.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 82657M105

     

      1.    

      Names of Reporting Persons.

     

      HH-IOP Partners, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

     

      (a)  ☐        (b)  ☑

      3.  

      SEC Use Only

     

      4.  

      Citizenship or Place of Organization

     

      Texas

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5.    

      Sole Voting Power

     

      0

       6.  

      Shared Voting Power

     

      0

       7.  

      Sole Dispositive Power

     

      0

       8.  

      Shared Dispositive Power

     

      0

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10.  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

      ☐

    11.  

      Percent of Class Represented by Amount in Row (9)

     

      0.0%

    12.  

      Type of Reporting Person (See Instructions)

     

      PN


    CUSIP No. 82657M105

     

      1.    

      Names of Reporting Persons.

     

      Mack H. Hicks

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

     

      (a)  ☐        (b)  ☑

      3.  

      SEC Use Only

     

      4.  

      Citizenship or Place of Organization

     

      United States

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5.    

      Sole Voting Power

     

      620,574 (1)

       6.  

      Shared Voting Power

     

      0

       7.  

      Sole Dispositive Power

     

      620,574 (1)

       8.  

      Shared Dispositive Power

     

      0

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      620,574 (1)

    10.  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

      ☐

    11.  

      Percent of Class Represented by Amount in Row (9)

     

      1.3% (2)

    12.  

      Type of Reporting Person (See Instructions)

     

      IN, HC

     

    (1)

    Includes (i) 86,206, shares of Common Stock held by Mack H. Hicks, as Trustee of the MHH 2016 Descendants Trust, and (ii) 444,588 shares of Common Stock held by MHH Ventures Ltd., which is ultimately owned and controlled by Mack H. Hicks.

    (2)

    Based upon 48,151,302 shares of Common Stock outstanding as of November 4, 2022, as disclosed in the issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022, that was filed by the issuer with the U.S. Securities and Exchange Commission on November 10, 2022.


    CUSIP No. 82657M105

     

      1.    

      Names of Reporting Persons.

     

      Thomas O. Hicks

      2.  

      Check the Appropriate Box if a Member of a Group (See Instructions)

     

      (a)  ☐        (b)  ☑

      3.  

      SEC Use Only

     

      4.  

      Citizenship or Place of Organization

     

      United States

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5.    

      Sole Voting Power

     

      0

       6.  

      Shared Voting Power

     

      0

       7.  

      Sole Dispositive Power

     

      0

       8.  

      Shared Dispositive Power

     

      0

      9.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10.  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

      ☐

    11.  

      Percent of Class Represented by Amount in Row (9)

     

      0.0%

    12.  

      Type of Reporting Person (See Instructions)

     

      IN, HC


    Item 1.

     

      (a)

    Name of Issuer

    Sight Sciences, Inc.

     

      (b)

    Address of Issuer’s Principal Executive Offices

    4040 Campbell Avenue, Suite 100

    Menlo Park, California 94025

    Item 2.

     

      (a)

    Name of Person Filing

    This statement is jointly filed by and on behalf of each of HEP Partners LLC, a Delaware limited liability company (“HEP Partners”), HH Sight LLC, a Texas limited liability company (“HH Sight”), HH Sight Partners GP L.P., a Texas limited partnership (“HH Sight GP”), HH Sight Partners, L.P., a Texas limited partnership (“HH Sight Partners”), HH-IOP Partners, L.P., a Texas limited partnership (“HH-IOP”), Mack H. Hicks, and Thomas O. Hicks (collectively referred to herein as the “Reporting Persons”). Prior to the effective date of this filing, Mack H. Hicks resigned as a director of the issuer, effective January 5, 2023. HH Sight GP is the general partner of, and may be deemed to indirectly beneficially own securities owned by, each of HH Sight Partners and HH-IOP. HH Sight is the general partner of, and may be deemed to indirectly beneficially own securities beneficially owned by, HH Sight GP. Mack H. Hicks and Thomas O. Hicks are the co-managers of, and may each be deemed to indirectly beneficially own securities owned by, HH Sight. HEP Partners is the investment manager of, and may be deemed to indirectly beneficially own securities owned by, each of HH Sight Partners and HH-IOP. Thomas O. Hicks is the Chairman, President, and Chief Executive Officer of, and may be deemed to indirectly beneficially own securities beneficially owned by, HEP Partners. As of December 31, 2022, no other Reporting Person, besides Mack H. Hicks, beneficially owns any security covered by this statement and each Reporting Person disclaims beneficial ownership of any such securities covered by this statement. HEP Partners, HH Sight, HH Sight GP, HH Sight Partners, HH-IOP, and Thomas O. Hicks disclaim beneficial ownership of any securities beneficially owned by Mack H. Hicks, as Trustee of the MHH 2016 Descendants Trust.

    Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement.

    Each of the Reporting Persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the issuer or otherwise with respect to the issuer or any securities of the issuer or (ii) a member of any group with respect to the issuer or any securities of the issuer.

     

      (b)

    Address of Principal Business Office or, if none, Residence

    The address of the principal business office of each of the Reporting Persons is c/o HEP Partners LLC, 2200 Ross Avenue, Suite 5000, Dallas, Texas 75201.

     

      (c)

    Citizenship

    See Item 4 on the cover page(s) hereto.


      (d)

    Title of Class of Securities

    Common Stock, par value $0.001 per share (“Common Stock”).

     

      (e)

    CUSIP Number

    82657M105

     

    Item 3.

    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is:

     

      (a)

    ☐     A broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

     

      (b)

    ☐     A bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);

     

      (c)

    ☐     An insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);

     

      (d)

    ☐     An investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

     

      (e)

    ☐     An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

     

      (f)

    ☐     An employee benefit plan or endowment fund in accordance with §240.13d- 1(b)(1)(ii)(F);

     

      (g)

    ☐     A parent holding company or control person in accordance with §240.13d- 1(b)(1)(ii)(G);

     

      (h)

    ☐     A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

      (i)

    ☐     A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment

                          Company

    Act of 1940 (15 U.S.C. 80a-3);

     

      (j)

    ☐     A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);

     

      (k)

    ☐     A group, in accordance with §240.13d-1(b)(1)(ii)(K).

    If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: _______________

     

    Item 4.

    Ownership

     

      (a)

    Amount beneficially owned: See Item 9 on the cover page(s) hereto.

     

      (b)

    Percent of class: See Item 11 on the cover page(s) hereto.

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote:  See Item 5 on the cover page(s) hereto.

     

      (ii)

    Shared power to vote or to direct the vote:  See Item 6 on the cover page(s) hereto.


      (iii)

    Sole power to dispose or to direct the disposition of: See Item 7 on the cover page(s) hereto.

     

      (iv)

    Shared power to dispose or to direct the disposition of: See Item 8 on the cover page(s) hereto.

     

    Item 5.

    Ownership of 5% or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ☒.

     

    Item 6.

    Ownership of More than 5% on Behalf of Another Person

    Not Applicable

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

    Not Applicable

     

    Item 8.

    Identification and Classification of Members of the Group

    Not Applicable

     

    Item 9.

    Notice of Dissolution of Group

    Not Applicable

     

    Item 10.

    Certifications

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect other than activities solely in connection with a nomination under § 240.14a-11.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: February 14, 2023     HEP PARTNERS LLC
        By:   /s/ Thomas O. Hicks
        Name:   Thomas O. Hicks
        Title:   Managing Member
        HH SIGHT LLC
        By:   /s/ Mack H. Hicks
        Name:   Mack H. Hicks
        Title:   Co-Manager
        HH SIGHT PARTNERS GP, L.P.
        By:   HH Sight LLC
        Its:   General Partner
        By:   /s/ Mack H. Hicks
        Name:   Mack H. Hicks
        Title:   Co-Manager
        HH SIGHT PARTNERS, L.P.
        By:   HH Sight Partners GP, L.P.
        Its:   General Partner
        By:   HH Sight LLC
        Its:   General Partner
        By:   /s/ Mack H. Hicks
        Name:   Mack H. Hicks
        Title:   Co-Manager
        HH-IOP PARTNERS, L.P.
        By:   HH Sight Partners GP, L.P.
        Its:   General Partner
        By:   HH Sight LLC
        Its:   General Partner
        By:   /s/ Mack H. Hicks
        Name:   Mack H. Hicks
        Title:   Co-Manager


    Thomas O. Hicks
    /s/ Thomas O. Hicks
    Mack H. Hicks
    /s/ Mack H. Hicks


    JOINT FILING AGREEMENT

    February 14, 2023

    Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended (the “Act”), and the rules and regulations thereunder, each party hereto hereby agrees to the joint filing, on behalf of each of them, of any filing required by such party under Section 13 or Section 16 of the Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with the Securities and Exchange Commission (and, if such security is registered on a national securities exchange, also with the exchange), and further agrees to the filing, furnishing, and/or incorporation by reference of this agreement as an exhibit thereto. This agreement shall remain in full force and effect until revoked by any party hereto in a signed writing provided to each other party hereto, and then only with respect to such revoking party.

    IN WITNESS WHEREOF, each party hereto, being duly authorized, has caused this agreement to be executed and effective as of the date first written above.

     

    Date: February 14, 2023

        HEP PARTNERS LLC
       

    By:

     

    /s/ Thomas O. Hicks

       

    Name:

     

    Thomas O. Hicks

       

    Title:

     

    Managing Member

        HH SIGHT LLC
       

    By:

     

    /s/ Mack H. Hicks

       

    Name:

     

    Mack H. Hicks

       

    Title:

     

    Co-Manager

        HH SIGHT PARTNERS GP, L.P.
       

    By:

     

    HH Sight LLC

       

    Its:

     

    General Partner

       

    By:

     

    /s/ Mack H. Hicks

       

    Name:

     

    Mack H. Hicks

       

    Title:

     

    Co-Manager

        HH SIGHT PARTNERS, L.P.
       

    By:

     

    HH Sight Partners GP, L.P.

       

    Its:

     

    General Partner

       

    By:

     

    HH Sight LLC

       

    Its:

     

    General Partner

       

    By:

     

    /s/ Mack H. Hicks

       

    Name:

     

    Mack H. Hicks

       

    Title:

     

    Co-Manager


        HH-IOP PARTNERS, L.P.
       

    By:

     

    HH Sight Partners GP, L.P.

       

    Its:

     

    General Partner

       

    By:

     

    HH Sight LLC

       

    Its:

     

    General Partner

       

    By:

     

    /s/ Mack H. Hicks

       

    Name:

     

    Mack H. Hicks

       

    Title:

     

    Co-Manager

        Thomas O. Hicks
       

    /s/ Thomas O. Hicks

        Mack H. Hicks
        /s/ Mack H. Hicks
    Get the next $SGHT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SGHT

    DatePrice TargetRatingAnalyst
    12/6/2024$5.50Buy
    UBS
    11/4/2024$10.00 → $5.00Buy → Hold
    Lake Street
    8/21/2024$10.00Buy
    Lake Street
    9/12/2023$10.00 → $4.50Neutral → Underperform
    BofA Securities
    9/12/2023$15.00 → $5.50Overweight → Neutral
    Piper Sandler
    9/12/2023Outperform → Mkt Perform
    William Blair
    8/24/2023$12.00 → $8.40Overweight → Equal-Weight
    Morgan Stanley
    7/10/2023$15.00 → $9.00Buy → Neutral
    Citigroup
    More analyst ratings

    $SGHT
    SEC Filings

    See more
    • SEC Form SD filed by Sight Sciences Inc.

      SD - Sight Sciences, Inc. (0001531177) (Filer)

      5/30/25 4:35:00 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by Sight Sciences Inc.

      10-Q - Sight Sciences, Inc. (0001531177) (Filer)

      5/8/25 4:16:05 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • Sight Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Sight Sciences, Inc. (0001531177) (Filer)

      5/8/25 4:08:25 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care

    $SGHT
    Financials

    Live finance-specific insights

    See more
    • Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

      MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today reported financial results for the first quarter ended March 31, 2025, reaffirms revenue guidance for full year 2025, and announces improved adjusted operating expenses guidance for full year 2025.   Recent Financial and Business Highlights Generated first quarter 2025 total revenue of $17.5 million, a decrease of 9% compared to the same period in the prior year. This decline was primarily due to lower revenue from the Company's

      5/8/25 4:05:00 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

      MENLO PARK, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced it will report financial results for the first quarter ended March 31, 2025, after the market close on Thursday, May 8, 2025. The Company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at

      4/24/25 4:05:00 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

      MENLO PARK, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today reported financial results for the fourth quarter and full year ended December 31, 2024 and initiated financial guidance for full year 2025. Recent Financial Highlights Generated fourth quarter 2024 total revenue of $19.1 million, an increase of 2% compared to the same period in the prior year, and full year 2024 total revenue of $79.9 million, a decrease of 1% compared to full year 2023.Achieved total gross marg

      3/5/25 4:05:00 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care

    $SGHT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Encrantz Staffan bought $451,734 worth of shares (128,189 units at $3.52), increasing direct ownership by 12% to 1,157,705 units (SEC Form 4)

      4 - Sight Sciences, Inc. (0001531177) (Issuer)

      5/29/25 9:31:17 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • EVP, Research & Development Raheja Manohar K. bought $53,250 worth of shares (20,000 units at $2.66) and was granted 24,000 shares, increasing direct ownership by 40% to 155,000 units (SEC Form 4)

      4 - Sight Sciences, Inc. (0001531177) (Issuer)

      3/13/25 9:51:29 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • EVP, Research & Development Raheja Manohar K. bought $19,250 worth of shares (5,000 units at $3.85), increasing direct ownership by 5% to 111,000 units (SEC Form 4)

      4 - Sight Sciences, Inc. (0001531177) (Issuer)

      12/9/24 6:16:25 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care

    $SGHT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Sight Sciences Inc.

      SC 13G/A - Sight Sciences, Inc. (0001531177) (Subject)

      11/14/24 11:57:36 AM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Sight Sciences Inc. (Amendment)

      SC 13G/A - Sight Sciences, Inc. (0001531177) (Subject)

      2/14/24 5:24:02 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Sight Sciences Inc.

      SC 13G - Sight Sciences, Inc. (0001531177) (Subject)

      2/13/24 6:52:37 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care

    $SGHT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UBS initiated coverage on Sight Sciences with a new price target

      UBS initiated coverage of Sight Sciences with a rating of Buy and set a new price target of $5.50

      12/6/24 8:14:13 AM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • Sight Sciences downgraded by Lake Street with a new price target

      Lake Street downgraded Sight Sciences from Buy to Hold and set a new price target of $5.00 from $10.00 previously

      11/4/24 8:26:06 AM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • Lake Street initiated coverage on Sight Sciences with a new price target

      Lake Street initiated coverage of Sight Sciences with a rating of Buy and set a new price target of $10.00

      8/21/24 8:27:48 AM ET
      $SGHT
      Medical/Dental Instruments
      Health Care

    $SGHT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th

      MENLO PARK, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced plans to present at the Stifel 2025 Virtual Ophthalmology Forum. Sight Sciences' management is scheduled to present on Tuesday, May 27, 2025, at 09:00 am PT / 12:00 pm ET. Interested parties may access a live and archived webcast of the fireside chat on the Investors section of the Company's website at https://investors.sightsciences.com/. About Sight Sciences Sight Sciences is an eyecar

      5/14/25 4:05:00 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

      MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today reported financial results for the first quarter ended March 31, 2025, reaffirms revenue guidance for full year 2025, and announces improved adjusted operating expenses guidance for full year 2025.   Recent Financial and Business Highlights Generated first quarter 2025 total revenue of $17.5 million, a decrease of 9% compared to the same period in the prior year. This decline was primarily due to lower revenue from the Company's

      5/8/25 4:05:00 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

      MENLO PARK, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced it will report financial results for the first quarter ended March 31, 2025, after the market close on Thursday, May 8, 2025. The Company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at

      4/24/25 4:05:00 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care

    $SGHT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Encrantz Staffan bought $451,734 worth of shares (128,189 units at $3.52), increasing direct ownership by 12% to 1,157,705 units (SEC Form 4)

      4 - Sight Sciences, Inc. (0001531177) (Issuer)

      5/29/25 9:31:17 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • EVP, Research & Development Raheja Manohar K. was granted 12,767 shares, increasing direct ownership by 8% to 167,767 units (SEC Form 4)

      4 - Sight Sciences, Inc. (0001531177) (Issuer)

      5/21/25 8:39:13 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Bauerlein Alison sold $45,430 worth of shares (13,066 units at $3.48), decreasing direct ownership by 2% to 636,728 units (SEC Form 4)

      4 - Sight Sciences, Inc. (0001531177) (Issuer)

      5/21/25 8:38:03 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care

    $SGHT
    Leadership Updates

    Live Leadership Updates

    See more
    • Sight Sciences Appoints Gary Burbach to its Board of Directors

      MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today that Gerhard (Gary) F. Burbach was appointed to the Company's Board of Directors on April 21, 2025. Mr. Burbach will serve as a Class II director with a term expiring at the 2026 Annual Meeting of Stockholders. "We are very excited to add Gary to our Board of Directors," stated Paul Badawi, Co-founder and Chief Executive Officer of Sight Sciences. "He brings a strong medtech industry background with a pro

      4/22/25 4:05:00 PM ET
      $BWXT
      $SGHT
      Industrial Machinery/Components
      Industrials
      Medical/Dental Instruments
      Health Care
    • Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

      MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences," or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today the appointment of MK Raheja, Ph.D. as its Executive Vice President, Research and Development, and Brenton Taylor as its Executive Vice President, Operations, effective November 4, 2024. Sight Sciences also announced that Sam Park, its Chief Operating Officer, who oversaw both R&D and Operations, will be retiring from his role at the Company effective November 15, 2024, and will remain available as a con

      11/7/24 4:04:00 PM ET
      $INGN
      $SGHT
      Industrial Specialties
      Health Care
      Medical/Dental Instruments
    • Sight Sciences Appoints Matt Link as Chief Commercial Officer

      MENLO PARK, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences," or the "Company"), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients' lives, today announced the appointment of Matthew Link as its Chief Commercial Officer, effective September 11, 2023. "We are very excited to have Matt join Sight Sciences as we scale our Surgical Glaucoma and Dry Eye businesses. Matt is a highly talented medtech business leader with a track record of success in transforming treatment paradigms with disruptive new technology, and predictably scaling in a public high-growth

      9/11/23 4:05:00 PM ET
      $SGHT
      Medical/Dental Instruments
      Health Care